Top Medical Stocks To Buy Right Now

New York, NY, based Investment company Grandfield & Dodd, Llc buys Enbridge, Johnson Controls International PLC, M&T Bank, Albemarle, Walt Disney Co, Gilead Sciences, US Bancorp, Abbott Laboratories, Vanguard Large-Cap ETF – DNQ, Clorox Co, sells Spectra Energy, St Jude Medical, Nordstrom, Emerson Electric Co, Chubb during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Grandfield & Dodd, Llc. As of 2017-03-31, Grandfield & Dodd, Llc owns 183 stocks with a total value of $810 million. These are the details of the buys and sells.

New Purchases: ENB, ALB, VV, BF.A, CHTR, CLX, MHK, NBIX, Added Positions: JCI, MTB, DIS, GILD, USB, ABT, BC, APD, CTSH, VOD, Reduced Positions: JWN, EMR, CACI, ADSK, VRSK, CB, MSFT, MDT, SEE, ITW, Sold Out: SE, STJ, BAC, GLD, WMT, JW.B, BIVV,

For the details of GRANDFIELD & DODD, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=GRANDFIELD+%26+DODD%2C+LLC

Top Medical Stocks To Buy Right Now: Cathay General Bancorp(CATY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Aurora Investment Counsel bought a new position in shares of Cathay General Bancorp (NASDAQ:CATY) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 43,515 shares of the bank’s stock, valued at approximately $1,803,000. Aurora Investment Counsel owned 0.05% of Cathay General Bancorp as of its most recent SEC filing.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Buy Right Now: Carter's, Inc.(CRI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Carter’s, Inc. (NYSE:CRI) has received an average rating of “Buy” from the fifteen research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $119.33.

  • [By Ethan Ryder]

    Carter’s, Inc. (NYSE:CRI) has earned a consensus recommendation of “Buy” from the fifteen ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have given a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $120.27.

  • [By Joseph Griffin]

    UBS Group initiated coverage on shares of Carter’s (NYSE:CRI) in a research note published on Thursday morning, www.benzinga.com reports. The firm issued a neutral rating and a $114.00 price target on the textile maker’s stock.

  • [By Max Byerly]

    Dimensional Fund Advisors LP grew its holdings in shares of Carter’s, Inc. (NYSE:CRI) by 2.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 450,812 shares of the textile maker’s stock after purchasing an additional 9,306 shares during the period. Dimensional Fund Advisors LP owned approximately 0.96% of Carter’s worth $46,930,000 at the end of the most recent reporting period.

Top Medical Stocks To Buy Right Now: Sina Corporation(SINA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Eagle Global Advisors LLC decreased its position in Sina Corp (NASDAQ:SINA) by 1.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,875 shares of the technology company’s stock after selling 1,595 shares during the period. Eagle Global Advisors LLC owned about 0.12% of Sina worth $8,850,000 at the end of the most recent quarter.

  • [By Steve Symington]

    Shares of SINA Corp. (NASDAQ:SINA) were down 10.2% as of 3:30 p.m. EDT Wednesday despite strong first-quarter 2018 results from the Chinese internet media company.

  • [By Leo Sun, Chuck Saletta, and Jordan Wathen]

    Leo Sun (SINA): SINA is one of China’s oldest internet companies, and it owns a network of portal sites and a controlling stake in Weibo, which it spun off back in 2014. SINA still generated nearly 80% of its sales from Weibo last quarter.

  • [By Leo Sun]

    Shares of SINA (NASDAQ:SINA) fell 7% on Aug. 8 after the Chinese internet company reported its second quarter earnings. Yet the decline, which brought SINA to a 52-week low, seemed unjustified, as the company easily beat analyst estimates.

  • [By Steve Symington]

    You wouldn’t know it by the market’s knee-jerk reaction, but SINA Corp. (NASDAQ:SINA) just announced another stronger-than-expected quarter early Wednesday. Shares of the Chinese internet media company fell 10% when all was said and done today — though it’s not the first time we’ve seen the stock fall on positive news.

  • [By Jack Delaney]

    SINA Corp. (Nasdaq: SINA) operates Weibo Corp. (Nasdaq: WB), a social media platform with 411 million monthly active users (MAUs) as of Q1 2018.

    It’s considered the Twitter Inc. (NYSE: TWTR) of China.

Top Medical Stocks To Buy Right Now: Tutor Perini Corporation(TPC)

Advisors’ Opinion:

  • [By Max Byerly]

    Tutor Perini Corp (NYSE:TPC) – Research analysts at KeyCorp upped their FY2019 EPS estimates for shares of Tutor Perini in a note issued to investors on Tuesday, August 7th. KeyCorp analyst S. Eastman now anticipates that the construction company will post earnings of $2.59 per share for the year, up from their prior forecast of $2.57.

  • [By Stephan Byrd]

    Engineers Gate Manager LP purchased a new stake in shares of Tutor Perini (NYSE:TPC) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 27,812 shares of the construction company’s stock, valued at approximately $613,000.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion.
    CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion.
    Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million.
    Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million.
    IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million.
    Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million.
    Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion.
    Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion.
    ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million.
    TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion.
    Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million.
    The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million.
    Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million.
    Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million.
    tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million.
    Copa Holdings,

  • [By Ethan Ryder]

    Tutor Perini Corp (NYSE:TPC) – Equities researchers at B. Riley increased their Q4 2018 earnings per share (EPS) estimates for shares of Tutor Perini in a report released on Wednesday, August 8th. B. Riley analyst A. Rygiel now expects that the construction company will post earnings per share of $0.88 for the quarter, up from their prior forecast of $0.87. B. Riley has a “Buy” rating and a $26.00 price target on the stock.

Top Medical Stocks To Buy Right Now: FirstService Corporation(FSV)

Advisors’ Opinion:

  • [By Max Byerly]

    Gazit Globe (NYSE:GZT) and FirstService (NASDAQ:FSV) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

  • [By Logan Wallace]

    PNC Financial Services Group Inc. decreased its stake in shares of FirstService Corp (NASDAQ:FSV) (TSE:FSV) by 4.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634,450 shares of the financial services provider’s stock after selling 28,902 shares during the period. PNC Financial Services Group Inc. owned 1.83% of FirstService worth $48,243,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    FirstService Corp (TSE:FSV) (NASDAQ:FSV) declared a quarterly dividend on Wednesday, September 12th, Zacks reports. Shareholders of record on Friday, September 28th will be given a dividend of 0.176 per share on Friday, October 5th. This represents a $0.70 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Thursday, September 27th. This is a positive change from FirstService’s previous quarterly dividend of $0.17.

  • [By Shane Hupp]

    ILLEGAL ACTIVITY NOTICE: “BB&T Securities LLC Acquires 1,782 Shares of FirstService Corp (FSV)” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at www.tickerreport.com/banking-finance/4158310/bbt-securities-llc-acquires-1782-shares-of-firstservice-corp-fsv.html.

Top Medical Stocks To Buy Right Now: Arena Pharmaceuticals, Inc.(ARNA)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Walgreens Boots Alliance (WBA) , Arena Pharmaceuticals (ARNA) , Dominion Energy (D) , Idexx Laboratories (IDXX) , GlaxoSmithKline (GSK) , Baidu.com (BIDU) , Baozun (BZUN) and Alibaba (BABA) .

  • [By Shane Hupp]

    Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have received a consensus rating of “Buy” from the eleven analysts that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $58.88.

  • [By Max Byerly]

    Rhumbline Advisers increased its holdings in Arena Pharmaceuticals (NASDAQ:ARNA) by 5.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 37,698 shares of the biopharmaceutical company’s stock after buying an additional 1,810 shares during the period. Rhumbline Advisers’ holdings in Arena Pharmaceuticals were worth $1,489,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Stephan Byrd]

    Partner Fund Management L.P. purchased a new position in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the 2nd quarter, HoldingsChannel reports. The fund purchased 1,196,891 shares of the biopharmaceutical company’s stock, valued at approximately $52,184,000.

  • [By ]

    Arena Pharmaceuticals (Nasdaq: ARNA) has completed Phase 2 evaluation of its Ralinepag program for pulmonary arterial hypertension (PAH). The drug was granted orphan status by the U.S. Food and Drug Administration in 2014 which brings faster case review and increased patent protection. 

Leave a Reply

Your email address will not be published. Required fields are marked *